Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/33472
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInder, Warrick J-
dc.contributor.authorGrossmann, Mathis-
dc.date2023-
dc.date.accessioned2023-08-09T04:43:08Z-
dc.date.available2023-08-09T04:43:08Z-
dc.date.issued2023-09-01-
dc.identifier.citationEuropean Journal of Endocrinology 2023-09-01; 189(3)en_US
dc.identifier.issn1479-683X-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/33472-
dc.language.isoeng-
dc.subjectSERMen_US
dc.subjectandrogenen_US
dc.subjectaromatase inhibitoren_US
dc.subjecthypogonadismen_US
dc.subjecttestosteroneen_US
dc.titleObesity and 'functional hypogonadism' - mechanisms and management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT".en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleEuropean Journal of Endocrinologyen_US
dc.identifier.affiliationDepartment of Diabetes and Endocrinology, Princess Alexandra Hospital,  Brisbane QLD, Australia.;Faculty of Medicine, The University of Queensland, Brisbane QLD, Australia.en_US
dc.identifier.affiliationMedicine (University of Melbourne)en_US
dc.identifier.affiliationEndocrinologyen_US
dc.identifier.doi10.1093/ejendo/lvad100en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-8261-3457en_US
dc.identifier.pubmedid37548170-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.deptEndocrinology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

54
checked on Oct 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.